Ernexa Therapeutics Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 11/05/2026 | Sep 2025Filed 07/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 11/05/2026 | Sep 2024Filed 07/11/2025 | Jun 2024Filed 13/08/2025 | Mar 2024Filed 07/05/2025 |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | $0.5 | $0 | $0 | |
| −$4 | −$5.5 | −$1.2 | −$3.1 | −$8.2 | −$27 | −$5.5 | −$6.6 | |
| −$3.40 | −$6.95 | −$0.15 | −$15.19 | −$57.76 | −$73.70 | −$15.34 | −$1.23 | |
| 1.2 | 0.8 | 8.2 | — | — | — | 0.4 | 5.4 |
Trend